Xilong Scientific Co., Ltd.

002584

CNE1000013M8

Commodity Chemicals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
5.96 ^CNY	-1.49%		-3.09%	-39.12%

Jul. 03	Xilong Scientific Co., Ltd. Announces Final Profit Distribution on A Shares for the Year 2023, Payable on 10 July 2024	CI
May. 20	Xilong Scientific Co., Ltd. Approves Cash Dividend for 2023	CI

Xilong Chemical Co.,Ltd agreed to acquire 75% stake in Newland Biotech from six individuals for CNY 92.3 million.

January 01, 2014 at 11:00 pm EST

Xilong Chemical Co.,Ltd (SZSE:002584) agreed to acquire 75% stake in Newland Biotech from six individuals for CNY 92.3 million on January 2, 2014.

Latest news about Xilong Scientific Co., Ltd.

Xilong Scientific Co., Ltd. Announces Final Profit Distribution on A Shares for the Year 2023, Payable on 10 July 2024	Jul. 03	CI
Xilong Scientific Co., Ltd. Approves Cash Dividend for 2023	May. 20	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Xilong Scientific Co., Ltd. Elects Non-Independent Directors	Feb. 01	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Xilong Scientific CFO Resigns; Successor Named	23-07-04	MT
Xilong Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-14	CI
Xilong Scientific Co., Ltd. announced that it has received CNY 1 billion in funding	22-08-11	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-21	CI
Xilong Scientific Co., Ltd. completed the acquisition of Xintai Yinghe New Energy Materials Co., Ltd. from Huang Yong, Lin Limin, Zeng Qingjun and Zeng Shihua.	22-04-06	CI
Xilong Scientific Co., Ltd. agreed to acquire Xintai Yinghe New Energy Materials Co., Ltd. from Huang Yong, Lin Limin, Zeng Qingjun and Zeng Shihua for approximately CNY 14 million on March 28, 2022.	22-03-28	CI
Jinan High-tech Industrial Development Co., Ltd, Jinan Gaoxin Finance Investment Co., Ltd and Jinan Gaoxin Shenghe Development Co., Ltd completed the acquisition of a 60% stake in Shandong ACV Biotech Co., Ltd from Xilong Scientific Co., Ltd..	22-02-15	CI
Jinan High-tech Industrial Development Co., Ltd, Jinan High-tech Industrial Development Co., Ltd and Jinan Gaoxin Shenghe Development Co., Ltd agreed to acquire a 60% stake in Shandong ACV Biotech Co., Ltd from Xilong Scientific Co., Ltd. for approximately CNY 500 million.	21-12-01	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-28	CI
Fulgent Genetics : to Invest $19 Million in Chinese Joint Venture, FF Gene Biotech	21-05-10	MT
Fulgent Genetics, Inc. Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech	21-05-10	CI
Fulgent Investment Development Limited entered into an agreement to acquire 40.5% stake in Fujian Fujun Gene Biotechnology Co., Ltd. from Xilong Scientific Co., Ltd. for approximately CNY 120 million.	21-05-07	CI
Xilong Scientific Co., Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Xilong Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI

Chart Xilong Scientific Co., Ltd.

Duration

Period

More charts

Xilong Scientific Co Ltd, formerly Xilong Chemical Co Ltd, is principally engaged in the research, development, production and sale of chemical reagents. The Company primarily provides general chemical reagents, including ammonia water, sodium hydroxide, sulfuric acid, nitric acid, carbinol and ethanol; chemical reagents for printed circuit boards (PCBs), as well as super clean high purity chemical reagents. Its chemical reagents are mainly used in electronic information, daily chemicals, medicine, food, as well as sensitization industries. The Company is also involved in chemical raw material, bulk pharmaceutical, food additive, and in-vitro diagnostic substance businesses.

Sector

Commodity Chemicals

Calendar

2024-08-23 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Commodity Chemicals

	1st Jan change	Capi.
XILONG SCIENTIFIC CO., LTD.	-39.12%	480M
AIR LIQUIDE	+3.77%	104B
SABIC	-5.15%	63.03B
PT CHANDRA ASRI PACIFIC TBK	+85.24%	52.26B
WANHUA CHEMICAL GROUP CO., LTD.	+7.15%	35.59B
LYONDELLBASELL INDUSTRIES N.V.	+3.85%	32.15B
WESTLAKE CORPORATION	+7.40%	19.33B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+16.25%	17.29B
HENGLI PETROCHEMICAL CO.,LTD.	+8.88%	13.9B
SOLAR INDUSTRIES INDIA LIMITED	+68.05%	12.75B

Other Commodity Chemicals

Xilong Scientific Co., Ltd.

Equities

002584

CNE1000013M8

Commodity Chemicals

Xilong Chemical Co.,Ltd agreed to acquire 75% stake in Newland Biotech from six individuals for CNY 92.3 million.

Latest news about Xilong Scientific Co., Ltd.

Chart Xilong Scientific Co., Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Commodity Chemicals